Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Centessa Pharmaceuticals(CNTA) the EBIT is -79.77 M (-159.2%);the EPS is -0.516 (-162.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.08B159.20%
----
----
EPS
-0.5161162.69%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf